Key Sessions
Takeshi Omasa
KEYNOTE: Next-generation Chinese hamster-derived host cell -development and characters
Graduate School of Engineering, Osaka University
Scott Gangloff
KEYNOTE: IND To BLA Technology Transfer Considerations
Incyte
Scott Gangloff
KEYNOTE: IND To BLA Technology Transfer Considerations
Incyte
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 2 (Exhibit Hall Open 9:15am-5:00pm) - PT (Pacific Time, GMT-08:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Main Conference Day 2 (Exhibit Hall Open 9:15am-5:00pm) - PT (Pacific Time, GMT-08:00)
search
Streams
Formats
6:30am - 7:15am
BPI US West 2024 Fun Run
7:30am - 8:25am
Coffee and Registration
Showing 6 of 6 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
Next Generation CAR & T Cell Therapies
8:25am - 8:30am
Chairperson Remarks
- Jacqualyn Schulman, Ph.D. - Senior Scientist, Cell Line Development & ‘Omics Biologics Development, Bristol-Myers Squibb
8:30am - 9:00am
Early Development of Next Generation Sequencing (NGS) for Clone Selection and Genetic Characterization
- Sofie O'Brien - Senior Scientist, BioProcess Development, Seagen
9:00am - 9:30am
NextGen Sequencing (NGS) platform and applications in cell line development
- Ying Shen - Director, Cell Line Development, Takeda Pharmaceuticals, Takeda Pharmaceuticals Co Ltd.
8:25am - 8:30am
Chairperson Remarks
- Aravindan Rajendran - Associate Research Fellow, Pfizer
8:30am - 9:00am
CSPR Driven Optimization of a High Intensity Dynamic Perfusion Process
- Peter Amaya, Ph.D. - Associate Director, AstraZeneca
9:00am - 9:30am
On the implementation of Raman spectroscopy-based monitoring and control for automated nutrient feeding strategies in mammalian cell cultures
- Ricardo Suarez Heredia - Scientist, Process Analytical Technology, Sanofi
8:25am - 8:30am
Chairperson Remarks
- Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
8:30am - 9:00am
Keynote Address: Challenges and Opportunities of Recombinant Adeno-associated Virus (rAAV) Process Development
- Chao Huang - Director of Downstream Process Development Pharmaceutical Development, Ultragenyx
9:00am - 9:30am
End to End digital twins – Save 50 % of experiments in Process Development and allow real time release in Manufacturing
- Christoph Herwig - Fr. Professor for Biochemical Engineering Senior Scientific Advisor, Körber Pharma Austria GmbH
8:25am - 8:30am
Chairperson Remarks
- Shalaka Purohit - Principal Consultant, Suveda Solutions LLC
8:30am - 9:00am
KEYNOTE: IND To BLA Technology Transfer Considerations
- Scott Gangloff - Vice President, Global Biopharmaceutical Development, Incyte
9:00am - 9:30am
Economics of Bioprocessing
- Joseph Pekny - Professor, Chemical Engineering, Purdue University
- Christopher Stevens - Chief Patient Supply Officer, Spark Therapeutics
8:25am - 8:30am
Chairperson Remarks
- Shalaka Purohit - Principal Consultant, Suveda Solutions LLC
8:30am - 9:00am
KEYNOTE: IND To BLA Technology Transfer Considerations
- Scott Gangloff - Vice President, Global Biopharmaceutical Development, Incyte
9:00am - 9:30am
Economics of Bioprocessing
- Joseph Pekny - Professor, Chemical Engineering, Purdue University
- Christopher Stevens - Chief Patient Supply Officer, Spark Therapeutics
8:25am - 8:30am
Chairperson Remarks
- Sherly Mardiana, PhD - Principal Scientist, Research/Discovery, Carisma Therapeutics
8:30am - 9:00am
Utilizing Biomarkers of Toxicity and Response in CAR T cell therapy
- Madison Davis - Senior Associate Scientist, Translational Pharmacology, Kite Pharma
9:00am - 9:30am
In vivo engineering of CAR T cells
- Edward Rebar - Chief Technology Officer, Sana Biotech
Showing 2 of 2 Streams
Networking Break
Poster Presentation & Viewing Session
9:30am - 10:30am
Morning Break
9:45am - 10:15am
Poster Presentation & Viewing Session in the Exhibit Hall
Head down to the Exhibit Hall to view our Scientific Posters and hear from the authors!
Showing 6 of 6 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
Next Generation CAR & T Cell Therapies
10:30am - 11:00am
Sialic acid modulation for enzyme fusions using combined approach of cell line engineering and cell culture process development
- Yashas Rajendra Ph.D. - Associate Director & Principal Scientist, Denali Therapeutics
11:00am - 11:30am
Microfluidic chip‐based single‐cell cloning and clone screening to enrich for high quality manufacturing cell lines
- Valerie Komatsu - Process Development Senior Scientist, Amgen
11:30am - 12:00pm
AI + Site-specific Integration Platform: AlfaCell
- Michael Chen, PhD - CEO & Co-founder, Great Bay Bio
10:30am - 11:00am
Sialic acid modulation for enzyme fusions using combined approach of cell line engineering and cell culture process development
- Yashas Rajendra Ph.D. - Associate Director & Principal Scientist, Denali Therapeutics
11:00am - 11:30am
Scaling-up therapeutic bioproduction with CELLiST BASAL CHO MX Medium
- Atul Joshi - Principal Scientist, Upstream Process Development, KBI Biopharma
11:30am - 12:00pm
Development of a Chemically Defined Growth Medium Specifically Designed for CHO DG44 Cells
- Luis Rodriguez - R&D Manager, Bioproduction, FUJIFILM Irvine Scientific
10:30am - 11:00am
Keynote Address: Case studies in sustainable biopharmaceutical manufacturing at AstraZeneca
- Alan Hunter - Executive Director, AstraZeneca
11:00am - 11:30am
Please move to another track
10:30am - 11:00am
Challenge and resolution of scaling up a novel antibody drug conjugate process
- Aaron Chen, Ph.D. - Director, BioProcess Development, Seagen
11:00am - 11:30am
NIIMBL Process Intensification Continuous Bioprocessing Facility Conceptual Design and Economics
- Raymond Szuszkiewicz - Licensed Senior Process Architect, IPS Integrated Project Services
- Jeff Johnson - President, Biotech Design, LLC
11:30am - 12:00pm
Accelerating Biologics: Streamline engineering and deployment of manufacturing platforms with Sartorius ProcessGo
- Charles Meadows - Process Technology Manager, Sartorius
10:30am - 11:00am
Keynote Address: Case studies in sustainable biopharmaceutical manufacturing at AstraZeneca
- Alan Hunter - Executive Director, AstraZeneca
11:00am - 11:30am
Digital Twins and Hybrid Models for Bioprocess Intensification and Optimization
- Krist Gernaey - Professor, Technical University of Denmark
11:30am - 12:00pm
Please Move To Another Track
10:30am - 11:00am
Importance of targeting both B cells and plasma cells to safely achieve immune reset and medication-free long-term remission; iCell CAR data in autoimmune disease
- Greg Deener - Chief Executive Officer, iCell Gene Therapeutics
11:00am - 11:30am
Next Generation T-regulatory Cells for Treatment of Autoimmune Diseases
- Daniel Shelly, Ph.D., MBA - Chief Business Development Officer, PolTREG
11:30am - 12:00pm
Please Move To Another Track
12:00pm - 1:25pm
Lunch
Showing 6 of 6 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
Next Generation CAR & T Cell Therapies
1:25pm - 1:30pm
Chairperson's Remarks
- Sofie O'Brien - Senior Scientist, BioProcess Development, Seagen
1:30pm - 2:00pm
Impact of gene copy number and configuration on antibody production in targeted integration CHO cell lines
- Zion Lee - Senior Scientist, Genentech
2:00pm - 2:30pm
Leveraging the Open Nature of Cell-Free Protein Synthesis for Production of Advanced Therapeutics
- Dan Groff - Senior Principal Scientist, Sutro Biopharma
2:30pm - 3:00pm
Integrating synthetic biology and computer-aided design to advance biologics production in CHO cells
- HaeWon Chung - Senior Synthetic Biologist, Asimov
1:25pm - 1:30pm
Chairperson's Remarks - Progress Towards Commercialization in the Cultured Meat Industry
- Bert Frohlich, Ph.D. - Principal and Owner, Biopharm Designs, LLC
1:30pm - 2:00pm
Cell Line Development in Cultivated Meat: accelerating development by oversampling the animal genome
- Sarah Bolmer - Vice President, Food and Nutrition, Triplebar
2:00pm - 2:30pm
Improving stem cell culture: serum replacement, homologous growth factors, and cost reduction
- Steven Rees - Co-founder and CEO, Defined Bioscience, Inc
2:30pm - 3:00pm
Accelerating Process Development Through Rapid Aggregate Screening
- Roger Connolly - Senior Scientist, R&D, Lonza Biologics
1:25pm - 1:30pm
Chairperson's Remarks
- Adam Goldstein - Senior Director, R+D Collaborations, Thermo Fisher Scientific
1:30pm - 2:00pm
Into the unknown: Planning and managing beyond the mAb
- Sheldon Oppenheim - Engineering Fellow, Takeda Pharmaceuticals
2:00pm - 2:30pm
Digital Twins and Hybrid Models for Bioprocess Intensification and Optimization
- Krist Gernaey - Professor, Technical University of Denmark
2:30pm - 3:00pm
Please move to another track
1:55pm - 2:00pm
Chairperson's Remarks
- Aaron Chen, Ph.D. - Director, BioProcess Development, Seagen
2:00pm - 2:30pm
Challenges and Solutions for a Successful Technology Transfer of a Legacy Monoclonal Antibody Process
- Christopher Brown - Senior Director, Technical Operations, Tourmaline Bio, Inc
2:30pm - 2:45pm
Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines
- Daniel Buckley - Director, Samsung Biologics
1:25pm - 1:30pm
Chairperson's Remarks
- Sherly Mardiana, PhD - Principal Scientist, Research/Discovery, Carisma Therapeutics
1:30pm - 2:00pm
In vivo programming of the immune system
- Haig Aghajanian - Co-Founder & Head of Research, Capstan Therapeutics
2:00pm - 2:30pm
Using Synthetic Biology to Realize the Promise of In Vivo Genetic Medicines
- Carlos Ibañez, PhD - Co-Founder, Chief Technology Officer, Abintus Bio
2:30pm - 3:00pm
Please move to another track
1:25pm - 1:30pm
Chairperson's Remarks
- Sherly Mardiana, PhD - Principal Scientist, Research/Discovery, Carisma Therapeutics
1:30pm - 2:00pm
In vivo programming of the immune system
- Haig Aghajanian - Co-Founder & Head of Research, Capstan Therapeutics
2:00pm - 2:30pm
Using Synthetic Biology to Realize the Promise of In Vivo Genetic Medicines
- Carlos Ibañez, PhD - Co-Founder, Chief Technology Officer, Abintus Bio
2:30pm - 3:00pm
Please move to another track
Showing 2 of 2 Streams
Networking Break
Poster Presentation & Viewing Session
3:00pm - 4:00pm
Afternoon Break
3:15pm - 3:45pm
Poster Presentation & Viewing Session in the Exhibit Hall
Head down to the Exhibit Hall to view our Scientific Posters and hear from the authors!
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
4:00pm - 4:30pm
Approaches to navigate specific productivity vs. growth seesaw in CHO cultures to maximize titer
- Shahram Misaghi, PhD - Staff Scientist, Genentech, Inc
4:30pm - 5:00pm
KEYNOTE: Next-generation Chinese hamster-derived host cell -development and characters
- Takeshi Omasa - Professor, Graduate School of Engineering, Graduate School of Engineering, Osaka University
4:00pm - 4:30pm
KEYNOTE ADDRESS - What can the Food Industry Teach Biopharma?
- Steven Lang - Vice President of Bioprocess Development, UPSIDE Foods
4:30pm - 5:00pm
Case Study: Scale-Up and Manufacturing for the Cultivated Meat Industry
- Nur Guven-Kuzey - Head of Bioprocess Development, Senior Process Development Engineer, Orbillion Bio
4:00pm - 4:30pm
Bioprocessing of Viral Vectors for Plant Engineering
- Stefano Menegatti - Associate Professor, North Carolina State University
4:30pm - 5:00pm
Making the Move from mAb to AAV
- Andrew Tustian - Senior Director, Regeneron
4:00pm - 4:30pm
Standardization and usage of drug substance manufacturing data across a global network
- Elaine Cho - Engineer II, Global MSAT and Engineering, Genentech
4:30pm - 5:00pm
KEYNOTE: Opportunities and Levers In Rapid Analytics For Bioprocessing 4.0
- Dhanuka Wasalathanthri, PhD - Associate Director, Bristol Myers Squibb
4:00pm - 4:30pm
Bioprocessing of Viral Vectors for Plant Engineering
- Stefano Menegatti - Associate Professor, North Carolina State University
4:30pm - 5:00pm
Making the Move from mAb to AAV
- Andrew Tustian - Senior Director, Regeneron
5:00pm - 6:30pm
Outdoor Evening Drinks Reception
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats